LinkedIn company pages are not a B2B marketing channel, and the data on organic reach proves it.
At SparkLife we run LinkedIn marketing audits for Medical Device and Life Science businesses, and the same pattern shows up almost every time: companies post regularly, generate a handful of likes from colleagues, see no leads, and start to wonder whether LinkedIn works at all.
By John Perkins
- Organic posts from LinkedIn company pages reach less than 10% of followers.
- Most company page followers are employees, competitors, and job seekers, not potential customers.
- LinkedIn paid is the channel that MedTech companies actually need to reach decision makers.
- The page still matters for credibility, employee advocacy, and as a prerequisite for paid ads.
According to Richard van der Blom's Algorithm Insights Report, based on analysis of 1.8 million LinkedIn posts, organic posts from company pages reach just 1.5 to 2% of followers. Our own client research shows Medical Device companies tend to do slightly better, around 8-10% of followers. That sounds encouraging until you look at who those followers actually are.
Company page followers are mostly made up of your own employees, competitors, suppliers and job seekers. When we strip those out for our MedTech clients, we’ve seen that only about 1 to 2% of the people seeing organic activity match the target customer profile. LinkedIn is ultimately restricting your organic content.
A LinkedIn company page exists to give your brand a home on the platform. It signals credibility to people who land on it after seeing an employee post or a paid ad. It enables your team to tag the company in their content. And it is a prerequisite for running campaigns through LinkedIn Campaign Manager. The page does those jobs well.
LinkedIn paid is extraordinarily powerful for Medical Device and Life Science companies when it is executed correctly. No other platform lets you target by job title, job function, seniority, company size, skills, and industry simultaneously. For a MedTech company trying to reach a hospital procurement director, a clinical imaging manager, or a Head of Cardiology, that level of precision is hard to replicate anywhere else.
LinkedIn's own B2B Institute data shows that LinkedIn-sourced leads convert at roughly three times the rate of leads from other paid social platforms. Combined with the targeting depth, that is the real reason MedTech marketers should be on LinkedIn. It is the paid channel, not the organic feed, that drives the pipeline.
The companies that consistently generate pipeline from LinkedIn share four habits:
1. They run paid campaigns with tightly defined audiences in Campaign Manager, layering job title, job function, seniority, and skills rather than relying on job title alone (which only matches around 35% of LinkedIn users).
2. They use the personal profiles of founders and senior leaders to publish thought leadership, then put that content in front of target accounts using Thought Leader Ads.
3. They treat LinkedIn as a content distribution channel, not an advertising break, leading with insight and value rather than product brochures.
4. They manage budgeting and bidding carefully, switching off defaults such as Maximum Delivery and the LinkedIn Audience Network, so spend stays inside the audience they actually defined.
Before investing in paid LinkedIn, get the basics right. Make sure your company page is complete and consistent, install the LinkedIn Insight Tag on your website so you can retarget visitors, and audit your senior team's personal profiles so they clearly communicate who you serve and what you stand for.
From there, even a modest paid budget, consistently applied to a well-defined audience with content that speaks to their real challenges, will outperform months of organic activity. The data is not ambiguous. The only question is how long you want to wait before acting on it.
Organic posts from LinkedIn company pages typically reach 1.5 to 2% of followers, according to Richard van der Blom's 2025 Algorithm Insights Report. Medical Device companies tend to see higher raw reach (around 8- 10%), but only a small fraction of those impressions are seen by target buyers.
Both, but for different jobs. Organic activity, particularly from senior leaders' personal profiles, builds credibility and trust. LinkedIn paid, run through Campaign Manager, is what actually delivers reach and pipeline against a defined target audience. For most B2B and MedTech companies, the company page on its own is not enough.
Medical Device buying decisions usually involve a complex matrix of clinicians, procurement, hospital administrators, and IT. LinkedIn is the only channel that lets you reach each of those roles with precise, role-specific messaging at scale. LinkedIn's own data shows leads from the platform convert at around three times the rate of other paid social platforms.
Yes. The LinkedIn platform is designed to monetise brand reach through paid campaigns. The secret to LinkedIn success is not to post more organic content, it is to put paid spend behind content that matters.
If you found this useful, sign up for our newsletter for more insights on healthcare and MedTech marketing.
SparkLife, founded by John Perkins and Carolyn Kelday, offers a proven marketing system designed to help life science companies navigate these challenges and reach their target audiences effectively. Their approach, which leverages digital expertise and strategic insights, has already demonstrated significant improvements in marketing performance. As the MedTech industry continues to evolve, marketers must remain agile, innovative, and customer-centric to drive growth and stay ahead of the competition.
